SEI Investments’s Rosetta Genomics Ltd. ROSG Stock Holding History

SEI Investments’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-270	Closed	–	–	3980
2018 Q1	$0	Hold	270	–	–	﹤0.01%	3859
2017 Q4	$0	Hold	270	–	–	﹤0.01%	3658
2017 Q3	$0	Hold	270	–	–	﹤0.01%	3580
2017 Q2	$1K	Hold	270	–	–	﹤0.01%	3034
2017 Q1	$1K	Sell	270 -1	-0.4%	-$5	﹤0.01%	2881
2016 Q4	$1K	Buy	+271	New	+$2.07K	﹤0.01%	2884

Other funds holding ROSG

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SEI Investments's ROSG Position: Q2 2018 in Review

SEI Investments sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2018, closing a stake of 270 shares.

SEI Investments first reported a position in ROSG in Q4 2016 and held it in 6 quarters. The position peaked at $1K in Q2 2017. 2 funds tracked by Wall St. Rank hold ROSG as of Q2 2018.

SEI Investments reported no remaining Rosetta Genomics Ltd. position as of Q2 2018 after selling out during the quarter.
SEI Investments sold 270 Rosetta Genomics Ltd. shares in Q2 2018.
SEI Investments first reported a position in Rosetta Genomics Ltd. in Q4 2016 and held it in 6 quarters.
SEI Investments's Rosetta Genomics Ltd. position peaked at $1K in Q2 2017.
2 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2018.

Based on SEI Investments's 13F filing for Q2 2018, filed 3 Aug 2018.